Burkhart Erin 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-02-24$68.38/sh−1,344$91,903→ 13,105 total
Footnotes (1)
- [F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.